PO.8.169 Immune responses to mrna vaccines against SARS-COV-2 in patients with immune-mediated inflammatory rheumatic diseases | Lupus Science & Medicine

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Friday 07 October 2022 from 13:00 to 14:10

PO.8 E- poster session 8: skin manifestations, SLE and infections, fertility and pregnancy, imaging

PO.8.169 Immune responses to mrna vaccines against SARS-COV-2 in patients with immune-mediated inflammatory rheumatic diseases

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Sieiro Santos C, Moriano Morales C, Díez Alvarez E

PO.8.169 Immune responses to mrna vaccines against SARS-COV-2 in patients with immune-mediated inflammatory rheumatic diseases

Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-elm2022.188